leisure time -WSS

leisure time

author：leisure time 2025-10-01 18:03:55 - browse：2

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Drinking less cuts risk of oral cavity, esophageal cancer: Report

knowledge

hotspot

WSS

Can sheer will power keep patients alive in their dying hours?

Carvykti CAR

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Paxlovid rebound happens. Why and to whom are still a mystery

What STAT readers think about the FDA and patient advocacy

Paxlovid rebound happens. Why and to whom are still a mystery

focus

leisure time

hotspot

23andMe had bad news about my health. I wish a person had delivered it

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

DIEP, the 'gold standard' of breast reconstruction, is under threat

With heat waves through August, officials warn of health risks

Psychedelics group wrestles with new pharma identity

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Kansas bar where gunfire wounded 9 last month closes permanently

Medicare details structure of new drug price negotiation program

Judge in Trump's classified documents case questions use of out

Wikipedia

SEC charges former device maker CEO with $41 million fraud

Hospitals owned by private equity see complications spike 25%

Keeping primary care docs in field isn't impossible, says AAFP CEO

Violet CEO on training clinicians to promote more inclusive care

'Brian's Song' at 50 still offers lessons about cancer for today

Pennsylvania man bitten on the head by bear during attack in his garage

knowledge

hotspot

hotspot

hotspot